K

Keith Kucinski's
email & phone

Opt-Out

Current Position:

Chief Financial Officer at Matinas BioPharma

Experience:

32 years

Location:

New York City Metropolitan Area

How to contact Keith Kucinski

Last updated:2025-06-06
emailk****k@matinasbiopharma.com
phone+1-***-***-8211
LinkedIn
GitHub
Facebook
Pinterest

Analytics

According to LinkedIn Keith Kucinski started working on 1993, then the employee has changed 8 companies and 6 jobs. On average, Keith Kucinski works for one company for 3 years 7 months. Keith Kucinski has been working as a Chief Financial Officer for Matinas BioPharma for 2404 days. If you are interested in this candidate, contact him directly by using contact details provided by SignalHire.

Work Experience

Chief Financial Officer at Matinas BioPharma

Jan 2019 - Current

Chief Financial Officer at RemedyOne

Jan 2018 - Sep 2018

Principal at High Ground Consulting LLC

Oct 2015 - Dec 2017

Vice President, Corporate Treasurer at Par Pharmaceutical

May 2009 - Oct 2015

Sr. Director, Finance & Corporate Development at Barr Pharmaceuticals, Inc.

Jan 2002 - May 2009

Treasury Manager | Business Unit Controller at ANADIGICS

Jan 2000 - Jan 2002

Manager, Corporate Tax Consulting at PwC

Jan 1998 - Jan 2000

Senior Accountant at Verizon

Jan 1996 - Jan 1998

Senior Accountant at Deloitte

Jan 1993 - Jan 1996

Education

MBA at NYU Stern School of Business

Bachelor of Business Administration - BBA at University of Notre Dame

Current Company Information Matinas BioPharma

Name: Matinas BioPharma

Location: Bedminster, New Jersey, United States

Employees: 10-50

Description: Matinas BioPharma (NYSE AMER: MTNB) is a biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (...

Frequently Asked Questions

How long has Keith Kucinski been working as a Chief Financial Officer?

Keith Kucinski's total experience in various companies as a Chief Financial Officer 1 year.

What is Keith Kucinski's minimum period of employment in the companies?

Keith Kucinski's minimum period of employment in various companies is 8 months.

What is Keith Kucinski's average duration of employment for different companies?

On average, Keith Kucinski works for one company for 3 years 2 months

What industries has Keith Kucinski worked in?

Keith Kucinski works in the Biotechnology. Previously, Keith Kucinski worked in the Hospital & Health Care, and Pharmaceuticals, and Semiconductors, and Information Technology and Services, and Management Consulting.

What positions has Keith Kucinski held before?

Previously, Keith Kucinski worked as a Chief Financial Officer, and Principal, and Vice President, Corporate Treasurer, and Sr. Director, Finance & Corporate Development, and Treasury Manager | Business Unit Controller.

How do I contact Keith Kucinski?

Keith Kucinski's email address is k****k@matinasbiopharma.com, phone number is +1-***-***-8211. Sign up to get contact details.

Who is the President/CEO/Director of the Matinas BioPharma?

The President/CEO/Director of the Matinas BioPharma is Eamonn Murphy

Who are Keith Kucinski's peers at other companies?

Keith Kucinski's peers at other companies are Wendy Ferrill and David Caloia and Sherie Breitenbach
Not the Keith Kucinski you were looking for?

Find email for 850M+ professionals

Similar profiles

Name
Company
Position
D
Chief Financial Officer
L
Anderson School Properties LLC
Chief Financial Officer
A
Chief Financial Officer
G
Faulconer Energy, LLC.
Chief Financial Officer
T
Wellvana
Chief Financial Officer
J
Chief Financial Officer
J
Wisconsin Housing Preservation Corporation (WHPC)
Chief Financial Officer
J
Healthcare Success, LLC
Chief Financial Officer

Other employees at Matinas BioPharma

Name
Company
Position
J
EVP, Chief Business Officer & General Counsel
P
Sr. Manager/Manager, cell based assays development
A
Vice President, Product Development and Technical Operations
H
Chief Technology Officer
N
Senior Analytical Chemist, Analytical Chemistry/Quality Control Department
P
Manager, Clinical Manufacturing
BACK TO TOP